The China’s Coronavirus Was A Weapon Of War. In Another Words A Weapon of Global Mass Distruction.

China and the Democrtic Party needs to be held responsable for the death’s due to the first coronavirus. Dr. Fauci has lied to the American people from the beginning of Covid. Being in Veteranary school I learned about this virus. There are 45 species registered as the coronaviuses. The mild illnesses in humans includes the common cold. (The common cold, also known simply as a cold, is a viral infections disease of the upper respiratory tract that primarily affects the respiratory mucosa of the nose, throat, sinuses, and larynx. The common cold, which also caused by other viruses, predominantly rhinoviruses), while more lethal varieties can cause Sars, Mers and Covid-19.                                                                                                                 The rhinovirus (from the Ancient Greek: rhis “nose” romanized: rhinos of the nose, and the Latin: virus) the most common viral infection agent in humans and is the predominant cause of the common cold. Rhinovirus proliferates in temperatures of 91-95 F, the temperatures found in the nose. Rhinoviruses belong to genus Enterovirus in the family Picornaviridae.                                           There are three species of rhinovirus recognized types in the human body. The human rhinovirus differ according to their surface proteins. They are lytic in nature and among the smallest viruses, with diameters of about 30 nanometers. By comparison, other viruses, such as smallpox and vaccinia, are around ten times larger at about 300 nanometers. While flu viruses are around 80-120 nm.

Transmission and epidemiology
Main article: Common cold
There are two modes of transmission: via aerosols of respiratory droplets and from fomites (contaminated surfaces), including direct person-to-person contact.

Rhinoviruses are spread worldwide and are the primary cause of the common cold. Symptoms include sore throat, runny nose, nasal congestion, sneezing and cough; sometimes accompanied by muscle aches, fatigue, malaise, headache, muscle weakness, or loss of appetite. Most sinus findings are reversible consistent with a self-limited viral process typical of rhinovirus colds. Fever and extreme exhaustion are more usual in influenza. Children may have six to twelve colds a year. In the United States, the incidence of colds is higher in the autumn and winter, with most infections occurring between September to April. The seasonality may be due to the start of the school year[citation needed] and to people spending more time indoors thereby increasing the chance of transmission of the virus.[5] Lower ambient temperatures, especially outdoors, may also be factor[6] given that rhinoviruses preferentially replicate at 32 °C (89 °F) as opposed to 37 °C (98 °F). Variant pollens, grasses, hays and agricultural practices may be factors in the seasonality as well as the use of chemical controls of lawn, paddock and sportsfields in schools and communities. The changes in temperature, humidity and wind patterns seem to be factors. It is also postulated that poor housing, overcrowding and unsanitary conditions related to poverty are relevant factors in the transmission of ‘common cold’.

The primary route of entry for human rhinoviruses is the upper respiratory tract (mouth and nose). Rhinovirus A and B use “major” ICAM-1 (Inter-Cellular Adhesion Molecule 1), also known as CD54 (Cluster of Differentiation 54), on respiratory epithelial cells, as receptors to bind to. Some subgroups under A and B uses the “minor” LDL receptor instead.[8] Rhinovirus C uses cadherin-related family member 3 (CDHR3) to mediate cellular entry.[9] As the virus replicates and spreads, infected cells release distress signals known as chemokines and cytokines (which in turn activate inflammatory mediators). Cell lysis occurs at the upper respiratory epithelium.

Infection occurs rapidly, with the virus adhering to surface receptors within 15 minutes of entering the respiratory tract. Just over 50% of individuals will experience symptoms within 2 days of infection. Only about 5% of cases will have an incubation period of less than 20 hours, and, at the other extreme, it is expected that 5% of cases would have an incubation period of greater than four and a half days.[10]

Human rhinoviruses preferentially grow at 32 °C (89 °F), notably colder than the average human body temperature of 37 °C (98 °F); hence the virus’s tendency to infect the upper respiratory tract, where respiratory airflow is in continual contact with the (colder) extrasomatic environment.

Rhinovirus C, unlike the A and B species, may be able to cause severe infections.[11] This association disappears after controlling for confounders.[12] Duly, amongst infants infected with symptomatic respiratory illness in low-resource areas, there appears to be no association between rhinovirus species and disease severity.[13]


Maximum likelihood phylogenetic trees of enterovirus species A, B, C, D and rhinovirus A, B, C isolates from Latin America. The 5’UTR region is much more affected by recombination events than the VP4/VP2 coding sequence. The paraphyletic nature of “rhinovirus” is visible.[14]
Rhinovirus was formerly a genus from the family Picornaviridae. The 39th Executive Committee (EC39) of the International Committee on Taxonomy of Viruses (ICTV) met in Canada during June 2007 with new taxonomic proposals. In April 2008, the International Committee on Taxonomy of Viruses voted and ratified the following changes:

2005.264V.04 To remove the following species from the existing genus Rhinovirus in the family Picornaviridae:
Human rhinovirus A
Human rhinovirus B
2005.265V.04 To assign the following species to the genus Enterovirus in the family Picornaviridae:
Human rhinovirus A
Human rhinovirus B
2005.266V.04 To remove the existing genus Rhinovirus from the family Picornaviridae. Note: The genus Rhinovirus hereby disappears.
The merge is based on the grounds that the two “genera” of viruses are not significantly different in a virological sense. They have identical genome organizations and particle structures, and the phylogeny is not always monophyletic.

In July 2009, the ICTV voted and ratified a proposal to add a third species, Human rhinovirus C to the genus Enterovirus.

2008.084V.A.HRV-C-Sp 2008.084V To create a new species named Human rhinovirus C in the genus Enterovirus, family Picornaviridae.
There have been a total of 215 taxonomic proposals, which have been approved and ratified since the 8th ICTV Report of 2005.

Human rhinovirus serotype names are of the form HRV-Xn where X is the rhinovirus species (A, B, or C) and n is an index number. Species A and B have used the same index, while Species C has a separate index. Valid index numbers are as follows:

Rhinovirus A: 1, 2, 7–13, 15, 16, 18–25, 28–34, 36, 38–41, 43–47, 49–51, 53–68, 71, 73–78, 80–82, 85, 88–90, 94–96, 98, 100–103
Rhinovirus B: 3–6, 14, 17, 26, 27, 35, 37, 42, 48, 52, 69, 70, 72, 79, 83, 84, 86, 91–93, 97, 99
Rhinovirus C: 1–51

Human rhinovirus genome, virion structure, and species
Rhinoviruses have single-stranded positive sense RNA genomes of between 7200 and 8500 nt in length. At the 5′ end of the genome is a virus-encoded protein and, as in mammalian mRNA, there is a 3′ poly-A tail. Structural proteins are encoded in the 5′ region of the genome and non structural at the 3′ end. This is the same for all picornaviruses. The viral particles themselves are not enveloped and are dodecahedral in structure.

The viral proteins are translated as a single, long polypeptide, which is cleaved into the structural and nonstructural viral proteins

Human rhinoviruses are composed of a capsid that contains four viral proteins, VP1, VP2, VP3 and VP4 VP1, VP2, and VP3 form the major part of the protein capsid. The much smaller VP4 protein has a more extended structure, and lies at the interface between the capsid and the RNA genome. There are 60 copies of each of these proteins assembled as an icosahedron. Antibodies are a major defense against infection with the epitopes lying on the exterior regions of VP1-VP3.

Novel antiviral drugs
Interferon-alpha used intranasally was shown to be effective against human rhinovirus infections. However, volunteers treated with this drug experienced some side effects, such as nasal bleeding, and began developing tolerance to the drug. Subsequently, research into the treatment was abandoned

Pleconaril is an orally bioavailable antiviral drug being developed for the treatment of infections caused by picornaviruses This drug acts by binding to a hydrophobic pocket in VP1, and stabilizes the protein capsid to such an extent that the virus cannot release its RNA genome into the target cell. When tested in volunteers, during the clinical trials, this drug caused a significant decrease in mucus secretions and illness-associated symptoms. Pleconaril is not currently available for treatment of human rhinoviral infections, as its efficacy in treating these infections is under further evaluation

Other substances such as Iota-Carrageenan may form a basis for the creation of drugs to combat the human rhinovirus.

In asthma, human rhinoviruses have been recently associated with the majority of asthma exacerbations for which current therapy is inadequate. Intercellular adhesion molecule 1 (ICAM-1) has a central role in airway inflammation in asthma, and it is the receptor for 90% of Human rhinoviruses. Human rhinovirus infection of airway epithelium induces ICAM-1.

Desloratadine and loratadine are compounds belonging to the new class of H1-receptor blockers. Anti-inflammatory properties of antihistamines have been recently documented, although the underlying molecular mechanisms are not completely defined. These effects are unlikely to be mediated by H1-receptor antagonism and suggest a novel mechanism of action that may be important for the therapeutic control of virus-induced asthma exacerbations.[citation needed]

In 2018, a new series of anti-rhinoviral compounds were reported by researchers at Imperial College London and colleagues at the University of York and the Pirbright Institute. These molecules target human N-myristoyltransferase, an enzyme in the host cell which picornavirus requires in order to assemble its viral capsid, and thus generate an infectious virion. The lead compound in this series, IMP-1088, very potently inhibited host myristoylation of viral capsid protein and prevented infectious virus formation, rescuing the viability of cells in culture which had been exposed to a variety of rhinovirus serotypes, or to related picornaviruses including poliovirus and foot-and-mouth-disease virus Because these compounds target a host factor, they are broadly active against all serotypes, and it is thought to be unlikely that they can be overcome by resistance mutations in the virus]

There are no vaccines against these viruses as there is little-to-no cross-protection between serotypes. At least 99 serotypes of human rhinoviruses affecting humans have been sequenced However, a study of the VP4 protein has shown it to be highly conserved among many serotypes of human rhinovirus, opening up the potential for a future pan-serotype human rhinovirus vaccineA similar result was obtained with the VP1 protein. Like VP4, VP1 also occasionally “pokes” out of the viral particle, making it available to neutralizing antibodies. Both peptides have been tested on rabbits, resulting in successful generation of cross-serotype antibodies.

The successful introduction of human ICAM-1 into mice has removed a major roadblock in creating an animal model for RV vaccination

Main article: Common cold § Prevention
Human rhinovirus can remain activated for up to three hours outside of a human host. Once the virus is contracted, a person is most contagious within the first three days. Preventative measures such as regular vigorous handwashing with soap and water may aid in avoiding infection. Avoiding touching the mouth, eyes, and nose, the most common entry points for rhinovirus may also aid in prevention. Droplet precautions, which take the form of a surgical mask and gloves, are the method used in major hospitals.

Rhinovirus and SARS-CoV-2
According to research[26] of the MRC-University of Glasgow Centre for Virus Research (CVR) scientists, human rhinovirus infection can block SARS-CoV-2 replication in cells of the respiratory tract by triggering an interferon response, and may reduce COVID-19 severity and disease burden.


                                                                                                                      As of  2021 Dr. Fauci has called all diseases and viruses the coronavirus.                                                                                                        Because of his laziness and incompentances to be a doctor is just scaring people to submit to the socialist wanting to take over the Christian people.                                                                                                      (I would love to write about these three issues all together, and I will just not now. Thats going to take more time to write. I will just keep adding to all my posts.                                                                                                                                         In humans and birds, the group of viruses respiratory tract infections that can range from mild to lethal.                                                                              If so many babies were not aborted, we may of found curse for all of these diseases

Author: Delana Zakrzewski

I am saved by the most High God for others sins against me any sins against the Lord God Almighty, Whose Son Jesus, washed us all of our sin by His presuses blood and beat death, by walking out of the Tomb

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: